Quantum Biopharma Ltd. Files 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Jul 8, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Jul 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, company-update
TL;DR
Quantum Biopharma (fka FSD Pharma) filed a 6-K, confirming 20-F annual reports and Toronto HQ.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on July 8, 2025. The company, incorporated in A6 with its principal executive office in Toronto, Canada, is reporting as a foreign private issuer. This filing is for the month of July 2025 and indicates the company files annual reports under Form 20-F.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Quantum Biopharma's status as a foreign private issuer. It confirms their reporting structure and location.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new financial or operational information that would typically indicate increased risk.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Registrant
- FSD Pharma Inc. (company) — Former company name
- July 8, 2025 (date) — Filing date
- Toronto, Canada (location) — Principal executive office
- Form 20-F (document) — Annual report form
- Form 6-K (document) — Filing type
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of July 2025.
What is the former name of Quantum Biopharma Ltd.?
The former name of Quantum Biopharma Ltd. was FSD Pharma Inc., with a date of name change on March 27, 2019.
Where is Quantum Biopharma Ltd.'s principal executive office located?
Quantum Biopharma Ltd.'s principal executive office is located at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.
Does Quantum Biopharma Ltd. file annual reports under Form 20-F or Form 40-F?
Quantum Biopharma Ltd. indicates that it files annual reports under cover of Form 20-F.
What is the SIC code for Quantum Biopharma Ltd.?
The Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 8, 2025 regarding Quantum Biopharma Ltd. (QNTM).